Cargando…

Ruxolitinib withdrawal due to the COVID-19

Detalles Bibliográficos
Autores principales: Lucijanic, Marko, Kusec, Rajko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966889/
https://www.ncbi.nlm.nih.gov/pubmed/33731851
http://dx.doi.org/10.1038/s41375-021-01214-4
_version_ 1783665758180474880
author Lucijanic, Marko
Kusec, Rajko
author_facet Lucijanic, Marko
Kusec, Rajko
author_sort Lucijanic, Marko
collection PubMed
description
format Online
Article
Text
id pubmed-7966889
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79668892021-03-17 Ruxolitinib withdrawal due to the COVID-19 Lucijanic, Marko Kusec, Rajko Leukemia Correspondence Nature Publishing Group UK 2021-03-17 2021 /pmc/articles/PMC7966889/ /pubmed/33731851 http://dx.doi.org/10.1038/s41375-021-01214-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Lucijanic, Marko
Kusec, Rajko
Ruxolitinib withdrawal due to the COVID-19
title Ruxolitinib withdrawal due to the COVID-19
title_full Ruxolitinib withdrawal due to the COVID-19
title_fullStr Ruxolitinib withdrawal due to the COVID-19
title_full_unstemmed Ruxolitinib withdrawal due to the COVID-19
title_short Ruxolitinib withdrawal due to the COVID-19
title_sort ruxolitinib withdrawal due to the covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966889/
https://www.ncbi.nlm.nih.gov/pubmed/33731851
http://dx.doi.org/10.1038/s41375-021-01214-4
work_keys_str_mv AT lucijanicmarko ruxolitinibwithdrawalduetothecovid19
AT kusecrajko ruxolitinibwithdrawalduetothecovid19